42 results on '"Adnot S"'
Search Results
2. Induction of telomerase in p21-positive cells counteracts capillaries rarefaction and preserves lung function of aging mice
3. Piezo1 in pulmonary arterial smooth muscle cells – A critical player for the development of pulmonary hypertension
4. Lung alveolar regeneration by p16 deletion in alveolar epithelial cells
5. Sénescence cellulaire et pathologies pulmonaires : exemple de la BPCO
6. Évaluation de l’inhibition de la voie JAK/STAT dans les modèles murins d’emphysème et de fibrose pulmonaires : effet sur la sénescence cellulaire
7. SARS-COV-2 infection causes massive lung-cell senescence
8. Chronic intermittent hypoxia leads to disruption of clock genes expression in mouse lung tissues: Potential consequences on lung cell senescence
9. MTOR dependent-induction of lung cell senescence leads to lung fibrosis or emphysema
10. Sérotonine et hypertension artérielle pulmonaire
11. 19 Polymorphisme du transporteur de la serotonine et hypertension pulmonaire dans la BPCO
12. Pulmonary vascular smooth muscle cells remodeling and dysfunction in cystic fibrosis
13. Involvement of interleukin-1 receptor (IL1R1) and myeloid differentiation primary response gene 88 (MyD88) signaling in pulmonary hypertension (PH)
14. The role of 5-HT2B receptors in development of valvulopathy, cardiomyopathy, and pulmonary hypertension in Fawn-Hooded rats
15. Differential effects of CX3CR1 and CCR2 deficiencies in hypoxic pulmonary hypertension
16. Senescence of pulmonary vascular cells is related to overactivation of the mTOR signaling pathway in chronic obstructive pulmonary disease (COPD)
17. Adeylyl cyclase 8 over-expression in vascular smooth muscle promotes the acquisition of inflammatory/migratory phenotype and development of pulmonary hypertension
18. Selective TSC1 deletion in smooth muscle results in mTOR signaling activation and development of pulmonary hypertension that can be reversed by rapamycin
19. Extracellular calpastatin protects against hypoxia-induced pulmonary hypertension (PH) in mice and is elevated in human PH
20. Pharmacological inhibition and genetic deletion of telomerase protect against pulmonary hypertension in mice
21. Effects of NO donors on hypoxic pulmonary hypertension in wild-type and SAD mice
22. CCR5 receptor is a new therapeutic target in pulmonary hypertension
23. Senescent Pulmonary-Artery Smooth Muscle Cell (PA-SMC)-derived osteopontin promotes PA-SMC proliferation in chronic obstructive pulmonary disease
24. Targeting the Calpain/Calpastatin system to protect against hypoxia-induced pulmonary hypertension in mice
25. Implication de l’IL-1β et de la voie de signalisation IL1R1/MyD88 dans la physiopathologie de l’hypertension artérielle pulmonaire (HTAP) expérimentale
26. Impact pronostique des troubles respiratoires du sommeil sur l’évolution de l’insuffisance cardiaque chronique : suivi prospectif de 384 patients
27. Vieillissement prématuré lié à une destruction précoce du poumon chez les fumeurs et au cours de la broncho-pneumopathie chronique obstructive
28. Caractéristiques et évolution des troubles respiratoires nocturnes (TRS) au cours de l’insuffisance cardiaque aiguë (ICA)
29. Role for dysregulated endothelium- derived FGF2 signaling in progression of pulmonary hypertension
30. 084 Deficiency in Tryptophan Hydroxylase 1 (TPH1) gene or C1473G Polymorphism of the TPH2 Gene Alter Development of Hypoxic Pulmonary Hypertension in Mice
31. 086 Altered Endothelin-1 (ET1) synthesis and ET1 receptors expression and function in idiopathic pulmonary hypertension: influence of BMPRII mutations
32. 085 Attenuated hypoxic pulmonary hypertension in interleukin-6 knockout mice
33. 083 Effect of Phosphodiesterase-4 Inhibition on Development of Monocrotaline – and Hypoxia – Induced Pulmonary Hypertension in Rats
34. Rôle de l’interleukine 6 (IL-6) et de monocyte chemoattractant protein 1 (MCP-1) dans le développement d’une hypertension pulmonaire dans la BPCO
35. 101 Un polymorphisme du gène codant pour l’IL-6 est un facteur de susceptibilité d’hypertension pulmonaire dans la BPCO
36. 020 Effets des cellules derives de la moelle osseuse dans un modèle d’agression pulmonaire vasculaire par la monocrotaline pyrrole chez la souris
37. 106 Contribution of the angiopoietin/Tie2 pathway to pulmonary artery smooth muscle hyperplasia in idiopathic pulmonary hypertension
38. 105 Caractéristiques cliniques, fonctionnelles, hémodynamiques pulmonaires et biologiques de patients atteints de bronchopneumopathie chronique obstructive, au repos et à l’exercice : données préliminaires
39. 107 Mice overexpressing the 5-hydroxytryptamine transporter in smooth muscle cells spontaneously develop pulmonary hypertension
40. Selective TSC1deletion in smooth muscle results in mTOR signaling activation and development of pulmonary hypertension that can be reversed by rapamycin
41. [Cellular senescence and pulmonary disease: COPD as an example].
42. [Serotonin and pulmonary arterial hypertension].
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.